Renerva Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$325K
- Investors
-
13
Renerva General Information
Description
Manufacturer of medical devices designed to improve healing following nerve injury. The company offers a nerve capping device, peripheral nerve matrix graft, sutureless neurorrhaphy device, implantable biomaterial matrix, nerve cap graft device, and tissue-based hydrogel, enabling medical professionals with tools to prevent neuroma formation and chronic pain.
Contact Information
Website
www.renerva.comCorporate Office
- 2403 Sidney Street
- Suite 280
- Pittsburgh, PA 15203
- United States
Corporate Office
- 2403 Sidney Street
- Suite 280
- Pittsburgh, PA 15203
- United States
Renerva Timeline
Renerva Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC | 30-Sep-2025 | $325K | Completed | Clinical Trials - General | ||
| 14. Later Stage VC | 15-Aug-2024 | Completed | Clinical Trials - General | |||
| 13. Grant | 01-Jan-2023 | Completed | Clinical Trials - General | |||
| 12. Grant | 24-Feb-2022 | Completed | Clinical Trials - General | |||
| 11. Early Stage VC | 01-Jun-2021 | Completed | Clinical Trials - General | |||
| 10. Accelerator/Incubator | 09-Jan-2020 | Completed | Clinical Trials - General | |||
| 9. Grant | 01-Sep-2019 | Completed | Clinical Trials - General | |||
| 8. Grant | 01-Jul-2019 | Completed | Clinical Trials - General | |||
| 7. Seed Round | 30-Apr-2019 | $960K | $2.02M | Completed | Clinical Trials - General | |
| 6. Grant | 14-Dec-2018 | $2.44M | $1.06M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Renerva Comparisons
Industry
Financing
Details
Renerva Competitors (4)
One of Renerva’s 4 competitors is Reapplix, a Venture Capital-Backed company based in Birkerod, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Reapplix | Venture Capital-Backed | Birkerod, Denmark | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Söring | Private Equity-Backed | Quickborn, Germany | ||||
| Arthrex | Private Equity-Backed | Naples, FL |
Renerva Patents
Renerva Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024411137-A1 | Nerve graft systems, devices, and methods | Pending | 27-Dec-2023 | ||
| EP-4832923-A1 | Nerve graft systems, devices, and methods | Pending | 27-Dec-2023 | ||
| WO-2025144768-A1 | Nerve graft systems, devices, and methods | Inactive | 27-Dec-2023 | ||
| AU-2022425103-A1 | Neurorrhaphy systems, devices, and methods | Pending | 31-Dec-2021 | ||
| AU-2022425103-A2 | Neurorrhaphy systems, devices, and methods | Pending | 31-Dec-2021 | A61B17/1128 |
Renerva Signals
Renerva Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chemical Angel Network | Angel Group | Minority | ||
| Cowtown Angels | Angel Group | Minority | ||
| Keiretsu Forum | Angel Group | Minority | ||
| Rochester Angel Network | Angel Group | Minority | ||
| Center for Life Science Ventures | Accelerator/Incubator | Minority |
Renerva FAQs
-
When was Renerva founded?
Renerva was founded in 2017.
-
Where is Renerva headquartered?
Renerva is headquartered in Pittsburgh, PA.
-
What is the size of Renerva?
Renerva has 10 total employees.
-
What industry is Renerva in?
Renerva’s primary industry is Therapeutic Devices.
-
Is Renerva a private or public company?
Renerva is a Private company.
-
What is Renerva’s current revenue?
The current revenue for Renerva is .
-
How much funding has Renerva raised over time?
Renerva has raised $2.98M.
-
Who are Renerva’s investors?
Chemical Angel Network, Cowtown Angels, Keiretsu Forum, Rochester Angel Network, and Center for Life Science Ventures are 5 of 13 investors who have invested in Renerva.
-
Who are Renerva’s competitors?
Reapplix, Spine Wave, Söring, and Arthrex are competitors of Renerva.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process